跳至主要内容
临床试验/CTRI/2022/04/042201
CTRI/2022/04/042201招募中未知

A study of association of Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) and dynapenia/sarcopenia with cardio-metabolic risks

ICMR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Adults of age 18-60 years, with fatty liver disease
  • Obese/Overweight individuals
  • Type 2 Diabetes Mellitus
  • Metabolically dysregulated Lean body individuals
  • Hand grip strength Men <28 kg, Women <18 kg
  • Appendicular skeletal muscle mass/height2
  • : Men <7.0kg/m2, Women <5.4 kg/m2.
  • SPPB=8 (The maximum score on the SPPB is:12)
  • 4-minute gait speed <0.8m/s.

排除标准

  • Pregnant women
  • Patient denying consent
  • Cirrhotic liver disease patients
  • Pediatric population

研究者

发起方
ICMR

相似试验